Interaction abolishment between mutant caveolin-1 Δ62-100 and ABCA1 reduces HDL-mediated cellular cholesterol efflux

Biochemical and Biophysical Research Communications

Volumn 414, Issue 2, 2011, Pages 337-343

  Kuo, Chan Yen ^a   Lin, Yu Chun ^a   Yang, Jaw Ji ^b   Yang, Vivian C ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ABCA1; Caveolin 1 62 100; Cholesterol efflux; Oligomerization

Indexed keywords

ABC TRANSPORTER A1; CAVEOLIN 1; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; ENDOTHELIUM CELL; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CAVEOLIN 1; CELLS, CULTURED; CHOLESTEROL; HEK293 CELLS; HUMANS; LIPOPROTEINS, HDL; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE DELETION;

RATTUS;

EID: 80054845679     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.070     Document Type: Article

References (28)

1. Chao W.T., Tai S.H., Lin Y.C., et al. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochem. Biophys. Res. Commun. 2005, 332:743-749.
2. Lin Y.C., Lin C.H., Kuo C.Y., et al. ABCA1 modulates the oligomerization and Golgi exit of caveolin-1 during HDL-mediated cholesterol efflux in aortic endothelial cells. BBRC 2009, 382:189-195.
3. O'Connell B.J., Denis M., Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 2004, 110:2881-2888.
4. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 1995, 36:211-228.
5. Frank P.G., Galbiati F., Volonte D., et al. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. Cell. Physiol. 2001, 280:C1204-C1214.
6. Galbiati F., Razani B., Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 2001, 106:403-411.
7. Spisni E., Tomasi V., Cestaro A., et al. Structural insights into the function of human caveolin 1. Biochem. Biophys. Res. Commun. 2005, 338:1383-1390.
8. Razani B., Lisanti M.P. Caveolins and caveolae: molecular and functional relationships. Exp. Cell Res. 2001, 271:36-44.
9. Bucci M., Gratton J.P., Rudic R.D., et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 2000, 6:1362-1367.
10. Liu P., Rudick M., Anderson R.G. Multiple functions of caveolin-1. J. Biol. Chem. 2002, 277:41295-41298.
11. Schlegel A., Lisanti M.P. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. J. Biol. Chem. 2000, 275:21605-21617.
12. Dietzen D.J., Hastings W.R., Lublin D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 1995, 270:6838-6842.
13. Sun X.H., Flynn D.C., Vincent C., et al. Identification of a novel domain at the N terminus of caveolin-1 that controls rear polarization of the protein and caveolae. J. Biol. Chem. 2007, 282:7232-7241.
14. Monier S., Parton R.G., Vogel F., et al. oligomerizes in vivo and in vitro. Mol. Biol. Cell 1995, 6:911-927.
15. Sargiacomo M., Scherer P.E., Tang Z., et al. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 1995, 92:9407-9411.
16. Lee H., Park D.S., Wang X.B., et al. Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. J. Biol. Chem. 2002, 277:34556-34567.
17. Machleidt T., Li W.P., Liu P., et al. Multiple domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 2000, 148:17-28.
18. Ren X., Ostermeyer A.G., Ramcharan L.T., et al. Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins. Mol. Biol. Cell 2004, 15:4556-4567.
19. Wang N., Silver D.L., Thiele C., et al. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 2001, 276:23742-23747.
20. Lin Y.C., Hsu W.C., Lo H.F., et al. Molecular interaction between caveolin-1 and ABCA1 on high-density lipoprotein mediated cholesterol efflux in rat aortic endothelial cells. Cardiovascular Res. 2007, 75:575-583.
21. Meshulam T., Simard J.R., Wharton J., et al. Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry 2006, 45:2882-2893.
22. Orso C., Broccardo W.E., Kaminske A., et al. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 2000, 24:192-196.
23. Yamamoto M., Toya Y., Jensen R.A., et al. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell Res. 1999, 247:380-388.
24. Schlegel A., Wang C., Pestell R.G., et al. Ligand-independent activation of oestrogen receptor alpha by caveolin-1. Biochem. J. 2001, 359:203-210.
25. Schreiber S., Fleischer J., Breer H., et al. A possible role for caveolin as a signaling organizer in olfactory sensory membranes. J. Biol. Chem. 2000, 275:24115-24123.
26. Kim J.H., Han J.M., Lee S., et al. Phospholipase D1 in caveolae: regulation by protein kinase Calpha and caveolin-1. Biochemistry 1999, 38:3763-3769.
27. García-Cardeña G., Fan R., Stern D.F., et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 1996, 271:27237-27240.
28. Schubert A.L., Schubert W., Spray D.C., et al. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002, 41:5754-5764.